Therefore, the purpose of this manuscript is to review current evidence for possible actions of GLP-1 and GIP/GLP-1 receptor agonists in the lungs, as well as data on their efficacy in most common respiratory disorders, and to establish whether there is room for further dedicated research in this field. Here, GIP is linked to respiratory system disorder.